News Tagged as ‘USFDA’
Ranbaxy may suffer Rs 300 cr revenue loss due to Imitrex delay
Saturday, January 3, 2009 1:30 pm No CommentsReportedly, drug major Ranbaxy Laboratories may suffer a significant revenue loss of nearly Rs 300 crore due to the delay in receiving the sanction from US Food
Aurobindo Pharma receives USFDA nod for 2 drugs
Wednesday, December 31, 2008 3:34 pm No CommentsAurobindo Pharma, drug maker today said it has got approvals from US drug regulator for Stavudine capsules and Stavudine oral solution, which are used in the treatment of HIV-1 infection.
USFDA tentatively sanctions Aurobindo Pharma’s drugs
Friday, December 5, 2008 11:48 am No CommentsUnited States Food & Drug Administration (USFDA) has tentatively approved Aurobindo Pharma for Perindopril Erbumine Tablets in dosages of 2mg, 4mg, 8mg and Eascitalopram Oxalate Oral Solution 5mg (base) / 5ml.
USFDA approves Divalproex Tablets for Orchid Chemicals
Thursday, December 4, 2008 12:18 pm No CommentsOrchid Chemicals & Pharmaceuticals has got US Food and Drug Association (USFDA) sanction for its ANDA (Abbreviated New Drug Application) for Divalproex Sodium Delayed-Release Tablets USP, 125 mg, 250 mg & 500 mg.